Clinical trial
Outcome of Use of Cytotoxic Drugs for Inflammatory Lung Diseases
NCT02356445 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Outcome of Use of Cytotoxic Drugs for Inflammatory Lung Diseases
- Lead sponsor
- University of Cincinnati
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2014
- Completion date
- December 31, 2018
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.